semaglutide acute kidney injury Semaglutides Are Poised to Remake Chronic Disease Care GLP-1 Side Effects and Semaglutide:

According to the International Diabetes Federation's Diabetes Atlas 11th Edition published in April 2025, an estimated 89.8 million adults in India were living with diabetes in 2024, making India the second-most affected country in the world after China

The market demands it

Retatrutide, known scientifically as LY3437943, is a triple agonist, working on three crucial hormone receptors that play significant roles in weight management: GLP-1, GIP, and GCG

A recent large-scale clinical trial has confirmed that tirzepatide, a dual GIP and GLP-1RAs, resulted in a weight loss of up to 20.9% in adults with body fat mass of 30 or more after 72-week follow-up [22]